Dermatol. praxi. 2013;7(1):21-25

Modern treatment of chronic venous disease

doc.MUDr.Dalibor Musil, Ph.D.
I. interní klinika kardiologická LF UP a FN Olomouc

Chronic venous disease refers to any long-term morphological and functional changes in the venous system accompanied by symptoms

and/or clinical signs that require examination and/or treatment. Rational therapy is compression and surgical removal of insufficient venous

segments with ultrasound-demonstrated reflux. Whether it is achieved with classic surgery, sclerotization, or some of the mini-invasive

endovascular methods is not of importance. Venous pharmacotherapy relieves venous symptoms and reduces venous oedema of the lower

limbs; however, it should always be used along with compression. The best management for venous leg ulcers is class 3 compression and

local treatment unless insufficient epifascial veins (the saphenous veins in particular) and perforators can be removed surgically. In chronic

or large ulcers, compression therapy and local treatment can be effectively supported by pharmacotherapy with pentoxifylline or MPFF.

Keywords: compression therapy, pharmacotherapy, surgical treatment, sclerotization, endovenous thermal ablation

Published: April 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Musil D. Modern treatment of chronic venous disease. Dermatol. praxi. 2013;7(1):21-25.
Download citation

References

  1. Bergan JJ, Schmid-Schönbein GW, Coleridge Smith PD, et al. Chronic venous disease. N Engl J Med 2006; 355: 488-498. Go to original source... Go to PubMed...
  2. Rutherford RB, Padberg FT Jr, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: An adjunct to venous outcome assessment. J Vasc Surg. 2000; 31: 1307-1312. Go to original source... Go to PubMed...
  3. Vasquez MA, Rabe E, McLafferty RB, Shortell CK, Marston WA, Gillespie D, Meissner MH, Rutherford RB. American Venous Forum Ad Hoc Outcomes Working Group: Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group. J Vasc Surg 2010; 52: 1387-1396. Go to original source... Go to PubMed...
  4. Consensus statement. Classification and Grading of Chronic Venous Disease in the Lower Limbs: A Consensus Statement. Phlebology 1995; 10: 42-45. Go to original source...
  5. Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification of chronic venous disorders. Consensus statement. J Vasc Surg 2004; 40: 1248-1252. Go to original source... Go to PubMed...
  6. Eklof B, Perrin M, Konstantinos TD, Rutherford RB, Gloviczki P. Updated terminology of chronic venous disorders: The VEIN-TERM transatlantic interdisciplinary consensus document. J Vasc Surg 2009; 49: 498-501. Go to original source... Go to PubMed...
  7. Franks PJ, Oldroyd MI, Dickson D, Sharp EJ, Moffatt CJ. Risk factors for leg ulcer recurrence: a randomized trial of two types of compression stoking. Age Ageing 1995; 490-494. Go to original source... Go to PubMed...
  8. Herman J. Kompresivní terapie v prevenci a léčbě žilních onemocnění dolních končetin. Interní Med 2009; 11: 126-128.
  9. Raju S, Neglén P. Chronic venous insufficiency and varicose veins. N Engl J Med 2009; 360: 2319-2327. Go to original source... Go to PubMed...
  10. Mazuch J, a kol. Chirurgické aspekty chronickej venóznej insuficiencie dolných končatín. Martin: Osveta 2006.
  11. van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg 2009; 49: 230-239. Go to original source... Go to PubMed...
  12. Murad MH, Coto-Yglesias F, Zumaeta-Garcia M, et al. A systematic review and meta-analysis of the treatments of varicose veins. J Vasc Surg. 2011; 53(5 Suppl): 49S-65S. Go to original source... Go to PubMed...
  13. Coleridge-Smith, P, Lo C, Ramelet AA. Venous leg ulcer: a meta-analysis of adjunctive therapy with micronized purified flavonoid fraction. Eur J Vasc Endovasc Surg 2005; 30: 198-208. Go to original source... Go to PubMed...
  14. Rojas AI, Phillips TJ. Patients with chronic leg ulcers show diminished levels of vitamins A and E, carotens and zinc. Dermatol Surg 1999; 25: 601-604. Go to original source... Go to PubMed...
  15. Browse, NL, Burnand, KG. The cause of venous ulceration. Lancet 1982; ii: 243-245. Go to original source... Go to PubMed...
  16. Jull AB, Waters J, Arroll B. Pentoxiphylline for treating venous leg ulcers. Cochrane Database of Systematic Reviews 2002; Issue 1. Art. No.: CD001733. Go to original source...
  17. Milio G, Mina C, Cospite V, et al. Efficacy of the treatment with prostaglandin E-1 in venous ulcers of the lower limbs. J Vasc Surg 2005; 42: 304-308. Go to original source... Go to PubMed...
  18. Coleridge-Smith P. Drug treatment of varicose veins, venous edema, and ulcers. S. 359-365, In: Gloviczki P, et al. Handbook of venous disorders. 3rd edition 2009, Hodder Arnold. Go to original source...
  19. Zamboni P, Cisno C, Marchetti F, et al. Minimally invasive surgical management of primary venous ulcers vs compression treatment: a randomized clinical trial. Eur J Vasc Endovasc Surg 2003; 25: 313-318. Go to original source... Go to PubMed...
  20. Guest M, Smith JJ, Tripuraneni G, et al. Randomized clinical trial of varicose vein surgery with compression versus compression alone for the treatment of venous ulceration. Phlebology 2003; 18: 130-136. Go to original source...
  21. Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.J Vasc Surg. 2011; 53(5 Suppl): 2S-48S. Go to original source... Go to PubMed...
  22. Musil D, Herman J. Diagnostika žilních onemocnění. s. 15-38. Ve: Herman J, Musil D, a kol. Žilní onemocnění v klinické praxi. 1. vydání, Praha: Grada 2011: 262.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.